Inhibition of miR-497-3p Downregulates the Expression of Procalcitonin and Ameliorates Bacterial Pneumonia in Mice


Pneumonia is usually caused by a wide variety of pathogen infection. The underlying mechanism contributing to pneumonia remains elusive. Here, the role of microRNA-497-3p (miR-497-3p) was explored in bacterial pneumonia. The expression levels of miR-497-3p and procalcitonin (PCT) in patient serum were detected by real-time polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA), respectively. The interaction between miR-497-3p and PCT was further verified in A549 cell line. To further explore the role of miR-497-3p in pneumonia, mouse model of bacterial pneumonia was established via Sp TIGR4 strain (SpT4) infection. Subsequently, LV-miR-497-3p sponge was administrated in mice with bacterial pneumonia. The severity of pneumonia and inflammatory response were evaluated. Serum miR-497-3p and PCT levels increased in patients with bacterial pneumonia and miR-497-3p level positively corrected with the PCT level. The functional assay demonstrated that CALCA is the target of miR-497-3p in the A549 cell line. In mice with bacterial pneumonia, both miR-497-3p and PCT levels were upregulated after SpT4 infection. LV-miR-497-3p sponge administration attenuated pneumonia, accompanied with increasing gain of bodyweight and blood oxygen levels, as well as uninjured lungs. miR-497-3p inhibition attenuates the expression of C-reactive protein (CRP) and inflammatory cytokines in lung tissues of SpT4-infected mice, including nterleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α). In conclusion, inhibition of miR-497-3p downregulates the expression of procalcitonin and ameliorates bacterial pneumonia in mice.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5


  1. 1.

    Mandell, L.A. 2015. Community-acquired pneumonia: an overview. Postgraduate Medicine 127: 607–615.

    Article  Google Scholar 

  2. 2.

    Thomas, C.F., Jr., and A.H. Limper. 2004. Pneumocystis pneumonia. The New England Journal of Medicine 350: 2487–2498.

    CAS  Article  Google Scholar 

  3. 3.

    Pfuntner, A., L.M. Wier, and C. Stocks. 2006. Most frequent conditions in U.S. hospitals, 2010: Statistical Brief #148. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville: Agency for Healthcare Research and Quality (US).

    Google Scholar 

  4. 4.

    Matuschak, G.M., and A.J. Lechner. 2010. Acute lung injury and the acute respiratory distress syndrome: pathophysiology and treatment. Missouri Medicine 107: 252–258.

    PubMed  PubMed Central  Google Scholar 

  5. 5.

    Jamieson, A.M., L. Pasman, S. Yu, P. Gamradt, R.J. Homer, T. Decker, and R. Medzhitov. 2013. Role of tissue protection in lethal respiratory viral-bacterial coinfection. Science 340: 1230–1234.

    CAS  Article  Google Scholar 

  6. 6.

    Skalski, J.H., T.J. Kottom, and A.H. Limper. 2015. Pathobiology of Pneumocystis pneumonia: life cycle, cell wall and cell signal transduction. FEMS Yeast Research 15: fov046.

    Article  Google Scholar 

  7. 7.

    Marriott, H.M., and D.H. Dockrell. 2006. Streptococcus pneumoniae: the role of apoptosis in host defense and pathogenesis. The International Journal of Biochemistry & Cell Biology 38: 1848–1854.

    CAS  Article  Google Scholar 

  8. 8.

    Henig, O., and K.S. Kaye. 2017. Bacterial pneumonia in older adults. Infectious Disease Clinics of North America 31: 689–713.

    Article  Google Scholar 

  9. 9.

    Aujla, S.J., Y.R. Chan, M. Zheng, M. Fei, D.J. Askew, D.A. Pociask, T.A. Reinhart, F. McAllister, J. Edeal, K. Gaus, S. Husain, J.L. Kreindler, P.J. Dubin, J.M. Pilewski, M.M. Myerburg, C.A. Mason, Y. Iwakura, and J.K. Kolls. 2008. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nature Medicine 14: 275–281.

    CAS  Article  Google Scholar 

  10. 10.

    Bartel, D.P. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281–297.

    CAS  Article  Google Scholar 

  11. 11.

    Croce, C.M., and G.A. Calin. 2005. miRNAs, cancer, and stem cell division. Cell 122: 6–7.

    CAS  Article  Google Scholar 

  12. 12.

    Guo, S., Y. Chen, J. Liu, J. Yang, C. Yang, T. Zhang, K. Jiang, Z. Wu, A. Shaukat, and G. Deng. 2019. miR-497a-5p attenuates lipopolysaccharide-induced inflammatory injury by targeting IRAK2. Journal of Cellular Physiology 234: 22874–22883.

    CAS  Article  Google Scholar 

  13. 13.

    Ma, W., Y. Kang, L. Ning, J. Tan, H. Wang, and Y. Ying. 2017. Identification of microRNAs involved in gefitinib resistance of non-small-cell lung cancer through the insulin-like growth factor receptor 1 signaling pathway. Experimental and Therapeutic Medicine 14: 2853–2862.

    Article  Google Scholar 

  14. 14.

    Self, W.H., R.A. Balk, C.G. Grijalva, D.J. Williams, Y. Zhu, E.J. Anderson, G.W. Waterer, D.M. Courtney, A.M. Bramley, C. Trabue, S. Fakhran, A.J. Blaschke, S. Jain, K.M. Edwards, and R.G. Wunderink. 2017. Procalcitonin as a marker of etiology in adults hospitalized with community-acquired pneumonia. Clinical Infectious Diseases 65: 183–190.

    CAS  Article  Google Scholar 

  15. 15.

    Wang, Y., B. Jiang, Y. Guo, W. Li, Y. Tian, G.F. Sonnenberg, J.N. Weiser, X. Ni, and H. Shen. 2017. Cross-protective mucosal immunity mediated by memory Th17 cells against Streptococcus pneumoniae lung infection. Mucosal Immunology 10: 250–259.

    Article  Google Scholar 

  16. 16.

    Yook, Y.S., J.S. Jeon, J.O. Park, and J.K. Kim. 2018. Laboratory investigation of trends in bacterial pneumonia in Cheonan, Korea, from January 2008 to September 2017. Journal of Microbiology and Biotechnology 28: 1730–1735.

    CAS  Article  Google Scholar 

  17. 17.

    Ambros, V. 2004. The functions of animal microRNAs. Nature 431: 350–355.

    CAS  Article  Google Scholar 

  18. 18.

    Bartel, D.P. 2009. MicroRNAs: target recognition and regulatory functions. Cell 136: 215–233.

    CAS  Article  Google Scholar 

  19. 19.

    Shen, L., J. Li, L. Xu, J. Ma, H. Li, X. Xiao, et al. 2012. miR-497 induces apoptosis of breast cancer cells by targeting Bcl-w. Experimental and Therapeutic Medicine 3: 475–480.

    CAS  Article  Google Scholar 

  20. 20.

    Zhu, W., D. Zhu, S. Lu, T. Wang, J. Wang, B. Jiang, Y. Shu, and P. Liu. 2012. miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2. Medical Oncology 29: 384–391.

    CAS  Article  Google Scholar 

  21. 21.

    Chen, X., C. Shi, C. Wang, W. Liu, Y. Chu, Z. Xiang, K. Hu, P. Dong, and X. Han. 2017. The role of miR-497-5p in myofibroblast differentiation of LR-MSCs and pulmonary fibrogenesis. Scientific Reports 7: 40958.

    CAS  Article  Google Scholar 

Download references


The study was supported by the Cangzhou Science and Technology Research and Development Program (cz151302039).

Author information



Corresponding author

Correspondence to Wenlong Wang.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Wang, W., Zhu, Y., Yin, L. et al. Inhibition of miR-497-3p Downregulates the Expression of Procalcitonin and Ameliorates Bacterial Pneumonia in Mice. Inflammation (2020).

Download citation


  • miR-497
  • PCT
  • Bacterial pneumonia